Write For Us

Coronavirus: Fiery debate in Canada's parliament over timeline for COVID-19 vaccine | HIGHLIGHTS

Sponsored Post Vitamin D2 Canada Persia
84 Views
Published
The House of Commons played host to a heated debate Thursday afternoon as multiple MPs including Conservative leader Erin O'Toole and NDP leader Jagmeet Singh demanded the government clarify when exactly Canadians can expect a COVID-19 vaccine to be delivered.

Federal Health Minister Patty Hadju and Conservative MP Michelle Rempel Garner drew condemnation from the Speaker of the House Thursday over an impassioned exchange between the two, during which Rempel Garner wondered if Hadju would have to apologize in April for "8000 dead Canadians" due to their delay in approving a COVID-19 vaccine.

The coronavirus pandemic has ravaged the world over the last 11 months, killing 1.4 million people around the world and 11,763 in Canada alone.

More than 350,000 Canadians have also been infected, along with more than 60 million others globally.

The Canadian government has contracts with seven of the leading vaccine candidate suppliers, with five of those vaccines now in Phase 3 clinical trials and several showing promising potential from those tests.

However, the specifics of a rollout schedule remain unclear and Prime Minister Justin Trudeau acknowledged earlier in the week that Canadians will receive the vaccine after citizens of countries like the U.S. and the U.K., where some of the leading vaccine candidates manufacture their supplies.

For more info, please go to https://globalnews.ca/news/7485916/coronavirus-vaccine-rollout-canada-priority-groups/

Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#covid19 #coronavirus #cdnpoli #GlobalNews
Category
U.S. & Canada
Tags
covid-19 vaccine, coronavirus vaccine, vaccine distrubtion
Sign in or sign up to post comments.
Be the first to comment